A Second Public Letter of Warning to Pfizer’s Executive Leadership: The Danger of Indiscriminate COVID-19 Vaccination in The Recently Infected

Dr. William Gruber, SVP of Vaccine Development at Pfizer (Left), and Dr. Albert Bourla, CEO at Pfizer (Right), have both been informed of the potential high risk of indiscriminately vaccinating the recently or currently SARS-CoV-2 infected during the COVID-19 pandemic.

Hooman Noorchashm MD, PhD is a physician-scientist. He is an advocate for ethics, patient safety and women’s health. He and his 6 children live in Pennsylvania.